Sato M, Nashan B, Ringe B, Grosse H, Barthels M, Pichlmayr R
Abdominal und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany.
Blood Coagul Fibrinolysis. 1991 Feb;2(1):25-31. doi: 10.1097/00001721-199102000-00004.
Detailed haemostatic changes were investigated during eight liver transplantations. The patients were divided into two groups; group 1 had minor operative bleeding (four cases) and group 2 had major bleeding (four cases). Group 2 had lower levels of platelets, fibrinogen, factor V (FV), and alpha 2-antiplasmin than group 1, and the thromboelastography showed fibrinolysis. In both groups, plasma tissue-plasminogen activator levels rose slightly. After revascularization of the graft liver, reductions in the values of PT, fibrinogen, FV and FVII were noted, along with a prolongation of the PTT and an increase in thrombin-antithrombin III complex levels. Plasma levels of protein C, protein S, antithrombin III, and plasminogen remained relatively stable throughout the operation. These results show that the preceding fibrinolysis and subsequent superimposed activation of the clotting system are the main causes of coagulopathy during liver transplantation, which correlate with the amount of operative haemorrhage and the abnormalities found in haemostatic tests.
在八例肝移植手术过程中对详细的止血变化进行了研究。患者被分为两组;第一组手术出血量少(四例),第二组出血量大(四例)。第二组的血小板、纤维蛋白原、凝血因子V(FV)和α2 - 抗纤溶酶水平低于第一组,血栓弹力图显示有纤溶现象。两组中,血浆组织型纤溶酶原激活剂水平均略有升高。移植肝血管再通后,观察到凝血酶原时间(PT)、纤维蛋白原、FV和凝血因子VII(FVII)值降低,同时部分凝血活酶时间(PTT)延长,凝血酶 - 抗凝血酶III复合物水平升高。在整个手术过程中,血浆蛋白C、蛋白S、抗凝血酶III和纤溶酶原水平保持相对稳定。这些结果表明,术前纤溶和随后叠加的凝血系统激活是肝移植期间凝血病的主要原因,这与手术出血量以及止血试验中发现的异常情况相关。